Invasive Fungal Disease in Immunocompromised Children: Current and Emerging Therapies
Details
Publication Year 2024-12-01,Volume 26,Issue #12,Page 235-244
Journal Title
Current Infectious Disease Reports
Publication Type
Review
Abstract
In an era of expanding indications for iatrogenic immunosuppression, invasive fungal disease (IFD) remains a significant challenge in immunocompromised children, with case fatality rates ranging from 10 to 70%. Understanding of current recommendations and recent evidence is essential to guide optimal IFD management.
Publisher
Springer Nature
Department(s)
Infectious Diseases
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2025-04-24 05:44:20
Last Modified: 2025-04-24 05:45:33

© 2025 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙